NeuraVia, Inc.

NeuraVia, Inc is a Delaware C-corp company developing AI solutions for neurological healthcare. Our flagship focus is building remote AI progression models for Alzheimer’s disease, enabling earlier detection, monitoring, and intervention. We are advancing regulatory approval through Advarra REB in the U.S. and Canada and are preparing for global market entry in Nigeria and India, where access to affordable, scalable neurological care is urgently needed.